GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » Cyclically Adjusted PS Ratio

Stryker (FRA:SYK) Cyclically Adjusted PS Ratio : 7.65 (As of Jun. 02, 2025)


View and export this data going back to . Start your Free Trial

What is Stryker Cyclically Adjusted PS Ratio?

As of today (2025-06-02), Stryker's current share price is €335.70. Stryker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €43.86. Stryker's Cyclically Adjusted PS Ratio for today is 7.65.

The historical rank and industry rank for Stryker's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:SYK' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.22   Med: 6.63   Max: 8.44
Current: 7.87

During the past years, Stryker's highest Cyclically Adjusted PS Ratio was 8.44. The lowest was 4.22. And the median was 6.63.

FRA:SYK's Cyclically Adjusted PS Ratio is ranked worse than
82.82% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs FRA:SYK: 7.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Stryker's adjusted revenue per share data for the three months ended in Mar. 2025 was €14.043. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €43.86 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stryker Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Stryker's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Cyclically Adjusted PS Ratio Chart

Stryker Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 7.50 6.12 6.88 7.61

Stryker Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.97 7.44 7.77 7.61 7.66

Competitive Comparison of Stryker's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Stryker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Stryker's Cyclically Adjusted PS Ratio falls into.


;
;

Stryker Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Stryker's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=335.70/43.86
=7.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Stryker's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=14.043/134.9266*134.9266
=14.043

Current CPI (Mar. 2025) = 134.9266.

Stryker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 5.686 100.684 7.620
201509 5.664 100.392 7.612
201512 6.590 99.792 8.910
201603 5.937 100.470 7.973
201606 6.678 101.688 8.861
201609 6.660 101.861 8.822
201612 7.895 101.863 10.458
201703 7.284 102.862 9.555
201706 7.058 103.349 9.215
201709 6.633 104.136 8.594
201712 7.698 104.011 9.986
201803 6.904 105.290 8.847
201806 7.481 106.317 9.494
201809 7.308 106.507 9.258
201812 8.781 105.998 11.177
201903 8.204 107.251 10.321
201906 8.512 108.070 10.627
201909 8.564 108.329 10.667
201912 9.779 108.420 12.170
202003 8.552 108.902 10.596
202006 6.536 108.767 8.108
202009 8.345 109.815 10.253
202012 9.190 109.897 11.283
202103 8.699 111.754 10.503
202106 9.323 114.631 10.974
202109 9.240 115.734 10.772
202112 10.883 117.630 12.483
202203 10.143 121.301 11.282
202206 11.121 125.017 12.003
202209 11.849 125.227 12.767
202212 12.848 125.222 13.844
202303 11.646 127.348 12.339
202306 12.012 128.729 12.590
202309 11.978 129.860 12.445
202312 13.897 129.419 14.488
202403 12.525 131.776 12.824
202406 13.070 132.554 13.304
202409 12.837 133.029 13.020
202412 15.915 133.157 16.126
202503 14.043 134.927 14.043

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stryker  (FRA:SYK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Stryker Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Stryker's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker Business Description

Address
1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.